No quarterly revenue total was found in PALOMINO LABORATORIES INC.'s SEC filings.
Palomino Laboratories Inc. (PALX) files with the SEC under industry code 3674, Semiconductors & Related Devices. Free cash flow was -$2.1 million. As of Jun 30, 2026 it held $19.4 million in cash and investments and $167,882 in total debt.
Revenue
—
Net income
$-1.37M
-450.5% vs year-ago quarter
Operating cash flow
$-1.12M
-1233.8% vs year-ago quarter
Free cash flow
$-2.06M
-43.8% vs prior quarter
EPS
$-0.06
-140.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
27.64M
+452.7% vs year-ago quarter
Net cash
$19.28M
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Semiconductors & Related Devices (SIC 3674)
- Listed as
- PALX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Goleta, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1938569
- Former names
- Unite Acquisition 3 Corp. (until Aug 29, 2025)
Other Semiconductors & Related Devices companies
- Nvidia Corp NVDA
- Broadcom Inc. AVGO
- Micron Technology Inc MU
- Advanced Micro Devices Inc AMD
- Intel Corp INTC
- Applied Materials Inc /DE AMAT
- Texas Instruments Inc TXN
- Arm Holdings PLC /UK ARM
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$1.4M | -$1.2M | -$742,639 | -$1.6M | -$337,445 |
| Net income | -$1.4M | -$1.2M | -$742,607 | -$1.8M | $389,417 |
| Diluted EPS | -$0.06 | -$0.07 | -$0.04 | -$0.54 | $0.15 |
| Operating cash flow | -$1.1M | -$1.1M | -$894,156 | -$309,762 | -$84,083 |
| Free cash flow | -$2.1M | -$1.4M | — | — | — |
| Total assets | $21.0M | $7.4M | $8.4M | $8.3M | $1,887 |
| Total liabilities | $475,962 | $351,970 | $336,458 | $999,013 | $364,431 |
| Stockholders' equity | $20.6M | $7.0M | $8.1M | $7.3M | -$447,236 |
| Cash and investments | $19.4M | $6.7M | $8.1M | $7.9M | — |
| Total debt | $167,882 | $181,929 | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K/A | Amended current report | Oct 14, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Aug 5, 2026 | Jul 31, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 16, 2026 | Jul 14, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Unregistered share sale
|
May 5, 2026 | Apr 30, 2026 |
All 52 Palomino Laboratories Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.